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This construed examination paper deals with the analysis of the effectiveness of treatment with 
peroral antidiabetic drugs – sulfphonylurea derivatives for 2nd type diabetics.  
In the theoretical section there are summarized the basic principles of screening and diagnosis 
of 2nd type diabetes. There is outlined algorithm of the selection of treatment and briefly 
described individual classes of peroral antidiabetic drugs. There is also a mention of other 
possibilities for pharmacotherapy of diabetes. More att ntion is given to peroral diabetic drugs 
from a group of sulfonylureas derivatives, where individual knowledge are supported by 
scientific studies.  
The aim of experimental part of study was to follow experiences with sulfphonylurea 
derivatives therapy on a group of patients treated in the medical facility Dům zdraví Havířov. 
There was followed the advantageousness of therapy and reasons for laying off the particular 
medicinal substances. 
I found that most patients had experience with glimepiride, and combinations of peroral 
antidiabetic drugs from sulfphonylurea group (SU-PAD) with metformin; gliquidon was most 
often ordained to elderly patients, whereas glimepiride to younger ones; and that the choice of 
SU-PAD was independent of patient’s gender.  
Preference in the selection of SU-PAD in the therapy of individual patients was assessed 
according to various parameters, the advantageousness of therapy, the treatment efficiency, 
side effects, the advantageousness of the combinations and weight reduction.  
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